Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
1.
Am J Med Genet A ; 188(8): 2421-2428, 2022 08.
Artículo en Inglés | MEDLINE | ID: mdl-35593535

RESUMEN

Maternal uniparental disomy of human chromosome 7 [upd(7)mat] is well-characterized as a cause of the growth disorder Silver-Russell syndrome (SRS). However, the causative gene is not currently known. There is growing evidence that molecular changes at the imprinted MEST region in 7q32.2 are associated with a phenotype evocative of SRS. This report details a patient with a SRS-like phenotype and a paternally inherited microdeletion of 79 kilobases (35-fold smaller than the previously reported smallest deletion) in the 7q32.2 region. This microdeletion encompasses only five genes, including MEST, which corroborates the hypothesis that MEST plays a central role in the 7q32.2 microdeletion growth disorder, as well as further implicating MEST in upd(7)mat SRS itself.


Asunto(s)
Síndrome de Silver-Russell , Cromosomas Humanos Par 7/genética , Impresión Genómica , Trastornos del Crecimiento/genética , Humanos , Herencia Paterna , Fenotipo , Síndrome de Silver-Russell/diagnóstico , Síndrome de Silver-Russell/genética , Disomía Uniparental/genética
2.
Pediatr Dermatol ; 39(1): 107-111, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34929758

RESUMEN

Porokeratotic eccrine ostial and dermal duct nevus (PEODDN) is a rare eccrine hamartoma; the etiology is incompletely understood. A patient presented with congenital, widespread PEODDN. Clinical assessment, histopathologic, cytogenetic, and molecular genetic investigations on affected cells were pursued. Histopathology confirmed PEODDN, and chromosomal microarray on affected tissues identified a mosaic 3p26.3p25.3 deletion in affected tissues. This 11Mb deletion encompasses 47 OMIM genes. We propose that this and other chromosomal deletions may be implicated in some cases of PEODDN, suggesting locus heterogeneity and underscoring the importance of incorporating cytogenetic and molecular investigations into the multidisciplinary care of individuals with suspected mosaic genetic skin disorders.


Asunto(s)
Hamartoma , Nevo , Poroqueratosis , Neoplasias Cutáneas , Enfermedades de las Glándulas Sudoríparas , Glándulas Ecrinas , Humanos , Poroqueratosis/genética
4.
Histopathology ; 64(5): 731-40, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24433523

RESUMEN

AIMS: Lipoblastoma is a benign neoplasm of embryonic white fat tissue that results from the proliferation of primitive adipocytes, in which histological features can be ambiguous. In order to discriminate between lipoblastoma and other lipogenic and lipomatous tumours, we studied chromosomal alterations and protein expression in two cases of lipoblastoma in infants. METHODS AND RESULTS: Standard cytogenetic analysis, fluorescence in-situ hybridization, array comparative genomic hybridization and Western blotting allowed us to demonstrate the presence of chromosome abnormalities involving the 8q11-13 region containing the pleomorphic adenoma gene 1 (PLAG1), which are classically reported in lipoblastoma, and aberrant expression of PLAG1. CONCLUSIONS: This report illustrates two different tumorigenic pathways implicating PLAG1 in lipoblastoma: amplification through multiple copies of a small marker chromosome derived from chromosome 8, and a paracentric inversion of the long arm of chromosome 8. Both these anomalies induced aberrant expression of PLAG1, emphasizing the role of PLAG1 in tumorigenesis. The aberrant expression of PLAG1 protein has been hypothesized, but this is the first report to demonstrate its occurrence in lipoblastoma.


Asunto(s)
Aberraciones Cromosómicas , Cromosomas Humanos Par 8/genética , Proteínas de Unión al ADN/genética , Lipoblastoma/diagnóstico , Lipoblastoma/genética , Neoplasias de los Tejidos Blandos/diagnóstico , Neoplasias de los Tejidos Blandos/genética , Biomarcadores de Tumor/genética , Biomarcadores de Tumor/metabolismo , Preescolar , Inversión Cromosómica , Hibridación Genómica Comparativa , Análisis Citogenético , Proteínas de Unión al ADN/metabolismo , Femenino , Amplificación de Genes , Expresión Génica , Humanos , Hibridación Fluorescente in Situ , Lactante , Lipoblastoma/patología , Masculino , Neoplasias de los Tejidos Blandos/patología
5.
Med Phys ; 39(9): 5697-707, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22957635

RESUMEN

PURPOSE: This paper intends to demonstrate the feasibility of truly combined PET/CT imaging and addresses some of the major challenges raised by this dual modality approach. A method is proposed to retrieve maximum accuracy out of limited resolution computed tomography (CT) scans acquired with positron emission tomography (PET) detectors. METHODS: A PET/CT simulator was built using the LabPET™ detectors and front-end electronics. Acquisitions of energy-binned data sets were made using this low spatial resolution CT system in photon counting mode. To overcome the limitations of the filtered back-projection technique, an iterative reconstruction library was developed and tested for the counting mode CT. Construction of the system matrix is based on a preregistered raster scan from which the experimental detector response is obtained. PET data were obtained sequentially with CT in a conventional manner. RESULTS: A meticulous description of the system geometry and misalignment corrections is imperative and was incorporated into the matrix definition to achieve good image quality. Using this method, no sinogram precorrection or interpolation is necessary and measured projections can be used as raw input data for the iterative reconstruction algorithm. Genuine dual modality PET/CT images of phantoms and animals were obtained for the first time using the same detection platform. CONCLUSIONS: CT and fused PET/CT images show that LabPET™ detectors can be successfully used as individual X-ray photon counting devices for low-dose CT imaging of the anatomy in a molecular PET imaging context.


Asunto(s)
Procesamiento de Imagen Asistido por Computador/métodos , Imagen Multimodal/métodos , Fotones , Tomografía de Emisión de Positrones , Tomografía Computarizada por Rayos X , Imagen Multimodal/instrumentación
6.
Am J Med Genet A ; 155A(11): 2705-12, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21964771

RESUMEN

Isodicentric chromosomes are among the structural abnormalities of the Y chromosome that are commonly identified in patients. The simultaneous 45,X cell line that is generated in cell division due to instability of the isodicentric Y chromosome [idic(Y)] has long been hypothesized to explain the variable sexual development of these patients, although gonads have been studied in only a subset of cases. We report here on the molecular localization of breakpoints in ten patients with an idic(Y). Breakpoints were mapped by FISH using BACs; gonads and fibroblasts were also analyzed when possible to evaluate the level of mosaicism. First, we demonstrate great tissue variability in the distribution of idic(Y). Second, palindromes and direct repeats were near the breakpoint of several idic(Y), suggesting that these sequences play a role in the formation of idic(Y). Finally, our data suggest that intercentromeric distance has a negative influence on the stability of idic(Y), as a greater proportion of cells with breakage or loss of the idic(Y) were found in idic(Y) with a greater intercentromeric distance. Females had a significantly greater intercentromeric distance on their idic(Y) than did males. In conclusion, our study indicates that the Y chromosome contains sequences that are more prone to formation of isodicentric chromosomes. We also demonstrate that patients with an intercentromeric distance greater than 20 Mb on their idic(Y) are at increased risk of having a female sexual phenotype.


Asunto(s)
Centrómero/genética , Rotura Cromosómica , Cromosomas Humanos Y/genética , Mosaicismo , Aberraciones Cromosómicas Sexuales , Cariotipo Anormal , Mapeo Cromosómico , Cromosomas Artificiales Bacterianos , Femenino , Disgenesia Gonadal/genética , Disgenesia Gonadal/patología , Gónadas/patología , Humanos , Hibridación Fluorescente in Situ , Masculino , Metafase , Fenotipo , Telómero/genética
8.
Mol Genet Genomic Med ; 8(1): e951, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31568709

RESUMEN

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy (LVH) in the absence of predisposing cardiovascular conditions. Pathogenic variants in at least 16 cardiac sarcomeric genes have been implicated in HCM, most of which act in a dominant-negative fashion. However loss-of-function (haploinsufficiency) is the most common disease mechanism for pathogenic variants in MYBPC3, suggesting that MYBPC3 complete deletion may play a role in HCM pathogenesis. Here, we investigate MYBPC3 complete deletion as a disease mechanism in HCM by analyzing two unrelated patients with confirmed diagnosis of HCM that tested negative by Sanger sequencing analysis. METHODS: MYBPC3 complete deletion was investigated by Multiplex ligation-dependent probe amplification (MLPA) and microarray analyses. The mechanism of deletion was investigated by interrogating the SINEBase database. RESULTS: Patient-1 was diagnosed with nonobstructive HCM in his mid-40s while undergoing assessment for palpitations, and patient-2 with obstructive HCM in his late-20s while undergoing systolic heart murmur assessment for an unrelated illness. MLPA testing revealed a heterozygous deletion of all MYBPC3 exons in both patients. Subsequent microarray testing confirmed these deletions which extended beyond the 5' and 3' ends of MYBPC3. Genomic assessment suggested that these deletions resulted from Alu/Alu-homologous recombination. CONCLUSION: Our results demonstrate that haploinsufficiency resulting from MYBPC3 complete deletion, potentially mediated by Alu recombination, is an important disease mechanism in cardiomyopathy and emphasizes the importance of copy number variation analysis in patients clinically suspected of HCM.


Asunto(s)
Elementos Alu , Cardiomiopatía Hipertrófica/genética , Proteínas Portadoras/genética , Cardiomiopatía Hipertrófica/patología , Eliminación de Gen , Recombinación Homóloga , Humanos , Masculino , Persona de Mediana Edad
9.
Int J Lab Hematol ; 41(1): 5-14, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29971938

RESUMEN

The detection of cytogenetic abnormalities in multiple myeloma (MM) has received more importance over last years for risk stratification and the new risk-adapted treatment strategies. Conventional G-banding analysis should be included in a routine procedure for the initial diagnostic workup for patients suspected of MM. However, the detection of chromosomal abnormalities in MM by conventional cytogenetics is limited owing to the low proliferative activity of malignant plasma cells as well as the low number of plasma cells in bone marrow specimens. Fluorescence in situ hybridization (FISH) or microarray-based technologies can overcome some of those drawbacks and detect specific target arrangements as well as chromosomal copy number changes. In this review, we will discuss different cytogenetic approaches and compare their strength and weakness to provide genetic information for risk stratification and prediction of outcome in MM patients.


Asunto(s)
Citogenética/métodos , Mieloma Múltiple/genética , Aberraciones Cromosómicas , Humanos , Hibridación Fluorescente in Situ , Medición de Riesgo , Análisis de Matrices Tisulares
10.
Phys Med Biol ; 62(2): 669-683, 2017 01 21.
Artículo en Inglés | MEDLINE | ID: mdl-28050968

RESUMEN

Individually coupled scintillation detectors used in positron emission tomography (PET) imaging suffer from important signal losses due to the suboptimal light collection from crystals. As only a fraction of the light is generally extracted from long and thin scintillators, it is important to identify and understand the predominant causes of signal loss in order to eventually recover it. This simulation study investigates the multiple factors affecting the light transport in high-aspect ratio LYSO scintillators wrapped in specular reflectors through a full factorial design. By exploring various combinations of crystal geometry, readout conditions and wrapping conditions, it was found that an optimum light output can only be achieved through a careful selection of highly reflective material along with high-transmittance optical adhesive used to bond the reflector. Decreasing the adhesive thickness was also found to have a positive outcome in most explored configurations, however to a much lesser extent. Suboptimal reflectivity and adhesive transmittance also lead to an asymmetric light output distribution dependent on the depth of interaction of the radiation, potentially degrading energy resolution. By identifying the factors causing the most significant scintillation light losses through a factorial design, the most promising detector configurations have been identified in the quest for optimal light collection from scintillators.


Asunto(s)
Luz , Método de Montecarlo , Tomografía de Emisión de Positrones/instrumentación , Conteo por Cintilación/instrumentación , Humanos , Tomografía de Emisión de Positrones/métodos , Conteo por Cintilación/métodos
12.
Phys Med Biol ; 59(3): 661-78, 2014 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-24442278

RESUMEN

The LabPET is an avalanche photodiode (APD) based digital PET scanner with quasi-individual detector read-out and highly parallel electronic architecture for high-performance in vivo molecular imaging of small animals. The scanner is based on LYSO and LGSO scintillation crystals (2×2×12/14 mm3), assembled side-by-side in phoswich pairs read out by an APD. High spatial resolution is achieved through the individual and independent read-out of an individual APD detector for recording impinging annihilation photons. The LabPET exists in three versions, LabPET4 (3.75 cm axial length), LabPET8 (7.5 cm axial length) and LabPET12 (11.4 cm axial length). This paper focuses on the systematic characterization of the three LabPET versions using two different energy window settings to implement a high-efficiency mode (250­650 keV) and a high-resolution mode (350­650 keV) in the most suitable operating conditions. Prior to measurements, a global timing alignment of the scanners and optimization of the APD operating bias have been carried out. Characteristics such as spatial resolution, absolute sensitivity, count rate performance and image quality have been thoroughly investigated following the NEMA NU 4-2008 protocol. Phantom and small animal images were acquired to assess the scanners' suitability for the most demanding imaging tasks in preclinical biomedical research. The three systems achieve the same radial FBP spatial resolution at 5 mm from the field-of-view center: 1.65/3.40 mm (FWHM/FWTM) for an energy threshold of 250 keV and 1.51/2.97 mm for an energy threshold of 350 keV. The absolute sensitivity for an energy window of 250­650 keV is 1.4%/2.6%/4.3% for LabPET4/8/12, respectively. The best count rate performance peaking at 362 kcps is achieved by the LabPET12 with an energy window of 250­650 keV and a mouse phantom (2.5 cm diameter) at an activity of 2.4 MBq ml−1. With the same phantom, the scatter fraction for all scanners is about 17% for an energy threshold of 250 keV and 10% for an energy threshold of 350 keV. The results obtained with two energy window settings confirm the relevance of high-efficiency and high-resolution operating modes to take full advantage of the imaging capabilities of the LabPET scanners for molecular imaging applications.


Asunto(s)
Tomografía de Emisión de Positrones/instrumentación , Animales , Calibración , Fluorodesoxiglucosa F18 , Imagenología Tridimensional , Ratones , Fantasmas de Imagen
13.
Bioanalysis ; 5(15): 1911-8, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23905864

RESUMEN

BACKGROUND: The challenge of quantifying two compounds in a single assay with drastic dynamic ranges is to obtain linearity without source or detector saturation at the mass spectrometer. RESULTS: In positive-ionization mode, the nonlinear relationships for Desmethyl Mebeverine Acid (DMAC) were demonstrated using three common strategies to overcome this issue: using offset voltage parameters, less-sensitive product ion or 13C mass SRM transitions. On the contrary, nonlinear relationships for DMAC were overcome if negative-ionization mode was used. Due to Mebeverine analytical LLOQ, dilution was not suitable for a single assay of Mebeverine and DMAC. However, polarity switching in negative mode for DMAC was successfully found to compensate for the nonlinearity at the mass spectrometer while preserving Mebeverine linear regression model in positive mode. CONCLUSION: The polarity switching strategy has demonstrated the advantage of improving linearity for analytes having different ionization polarities and three orders of magnitude difference in concentration.


Asunto(s)
Anticonvulsivantes/análisis , Cromatografía Líquida de Alta Presión/métodos , Fenetilaminas/análisis , Espectrometría de Masas en Tándem/métodos , Anticonvulsivantes/sangre , Anticonvulsivantes/química , Anticonvulsivantes/metabolismo , Calibración , Humanos , Límite de Detección , Estructura Molecular , Dinámicas no Lineales , Fenetilaminas/sangre , Fenetilaminas/química , Fenetilaminas/metabolismo , Estándares de Referencia , Análisis de Regresión , Soluciones
14.
Bioanalysis ; 4(8): 897-908, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22533564

RESUMEN

BACKGROUND: In the past several years, the impact of changing counter ions while keeping the same anticoagulant in bioanalytical LC-MS/MS methods has become a highly discussed topic. In order to confirm that there is no impact from counter ions, matrix effect and stability evaluations were performed on bicalutamide LC-MS/MS bioanalytical methods. RESULTS: Independently from the anticoagulant counter ion used, the matrix effect evaluation met acceptance criteria, even when using conditions expected to increase matrix effect, such as protein precipitation with an analog internal standard. Freeze-thaw along with storage stabilities, namely short- and long-term, demonstrated less than 8% deviation regardless of the counter ion used. CONCLUSION: Differences in the anticoagulant counter ion used has no impact on the bicalutamide bioanalytical LC-MS/MS method.


Asunto(s)
Anilidas/sangre , Anticoagulantes/química , Cromatografía Liquida/métodos , Nitrilos/sangre , Espectrometría de Masas en Tándem/métodos , Compuestos de Tosilo/sangre , Anilidas/química , Ácido Edético/sangre , Ácido Edético/química , Humanos , Iones/química , Nitrendipino/sangre , Nitrendipino/química , Nitrilos/química , Compuestos de Tosilo/química
15.
J Nucl Med ; 53(8): 1300-9, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22699999

RESUMEN

UNLABELLED: The National Electrical Manufacturers Association (NEMA) standard NU 4-2008 for performance measurements of small-animal tomographs was recently published. Before this standard, there were no standard testing procedures for preclinical PET systems, and manufacturers could not provide clear specifications similar to those available for clinical systems under NEMA NU 2-1994 and 2-2001. Consequently, performance evaluation papers used methods that were modified ad hoc from the clinical PET NEMA standard, thus making comparisons between systems difficult. METHODS: We acquired NEMA NU 4-2008 performance data for a collection of commercial animal PET systems manufactured since 2000: microPET P4, microPET R4, microPET Focus 120, microPET Focus 220, Inveon, ClearPET, Mosaic HP, Argus (formerly eXplore Vista), VrPET, LabPET 8, and LabPET 12. The data included spatial resolution, counting-rate performance, scatter fraction, sensitivity, and image quality and were acquired using settings for routine PET. RESULTS: The data showed a steady improvement in system performance for newer systems as compared with first-generation systems, with notable improvements in spatial resolution and sensitivity. CONCLUSION: Variation in system design makes direct comparisons between systems from different vendors difficult. When considering the results from NEMA testing, one must also consider the suitability of the PET system for the specific imaging task at hand.


Asunto(s)
Tomografía de Emisión de Positrones/estadística & datos numéricos , Sociedades/estadística & datos numéricos , Animales , Procesamiento de Imagen Asistido por Computador , Ratones , Tomografía de Emisión de Positrones/instrumentación , Tomografía de Emisión de Positrones/normas , Control de Calidad , Dispersión de Radiación , Sensibilidad y Especificidad , Factores de Tiempo
16.
Pediatr Dev Pathol ; 14(6): 445-59, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21692598

RESUMEN

Patients with XY gonadal dysgenesis are at increased risk of developing gonadal tumors. The etiology of several cases of XY gonadal dysgenesis remains unknown, but X/XY gonadal mosaicism has been hypothesized to play a role. At the histologic level, the presence of persistent primitive sex cords containing immature germ cells in dysgenetic gonads (an entity called undifferentiated gonadal tissue, or UGT) was recently described, and these immature germ cells are thought to be at risk of neoplastic transformation. To further investigate both these aspects, we retrospectively studied the gonads from 30 patients with pure (22) and mixed (8) gonadal dysgenesis. Cytogenetic analyses performed on 35 gonads revealed that structurally abnormal Y chromosomes were lost in a majority of cells from the gonads, explaining the gonadal dysgenesis of patients bearing a rearranged Y chromosome. On the other hand, normal Y chromosomes were less often lost in gonads of patients with gonadal dysgenesis. At the histologic level, 43 of the 51 gonads presented areas characteristic of a streak; 13 of these streak gonads also presented areas of UGT. Structures resembling sex cords but without germ cells were found in many of the streaks not containing UGT, suggesting that UGT was initially present. Of the 13 gonads containing both UGT and a streak, 9 developed a tumor. The proximity of UGT with the tumors as well as the immunostaining patterns (PLAP+, OCT3/4+, and CD117/KIT+) suggests that germ cells found in UGT are a risk factor for gonadal tumors.


Asunto(s)
Inestabilidad Cromosómica , Cromosomas Humanos Y , Disgenesia Gonadal 46 XY/patología , Gonadoblastoma/patología , Neoplasias Ováricas/patología , Neoplasias Testiculares/patología , Fosfatasa Alcalina/metabolismo , Biomarcadores de Tumor/metabolismo , Diferenciación Celular , Femenino , Proteínas Ligadas a GPI/metabolismo , Disgenesia Gonadal 46 XY/genética , Disgenesia Gonadal 46 XY/metabolismo , Gonadoblastoma/genética , Gonadoblastoma/metabolismo , Humanos , Hibridación Fluorescente in Situ , Isoenzimas/metabolismo , Cariotipificación , Masculino , Factor 3 de Transcripción de Unión a Octámeros/metabolismo , Neoplasias Ováricas/genética , Neoplasias Ováricas/metabolismo , Proteínas Proto-Oncogénicas c-kit/metabolismo , Estudios Retrospectivos , Neoplasias Testiculares/genética , Neoplasias Testiculares/metabolismo
17.
Bioanalysis ; 3(9): 951-65, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21545343

RESUMEN

BACKGROUND: Reanalysis of incurred samples showed that the bioanalytical method for the quantification of ramipril and ramiprilat was generating irreproducible results for ramiprilat. RESULTS: An additional peak interfering with ramiprilat was observed in the incurred samples but not in the calibrant and quality control samples. A similar interference was detected for ramipril, but it was chromatographically separated. Interferences were produced during sample preparation, which involves strong cation exchanger cartridges. The interfering products corresponded to the methylation of ramipril and ramiprilat glucuronide. CONCLUSION: Following this discovery, a reproducible method was developed and successfully validated for ramipril and ramiprilat. Additional stability tests were performed in the presence of glucuronide and diketopiperazine metabolites of ramipril and ramiprilat to demonstrate the method specificity.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/sangre , Artefactos , Dicetopiperazinas/sangre , Glucurónidos/sangre , Ramipril/análogos & derivados , Ramipril/sangre , Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Calibración/normas , Enfermedades Cardiovasculares/tratamiento farmacológico , Cromatografía Líquida de Alta Presión , Cromatografía por Intercambio Iónico , Guías como Asunto , Humanos , Espectrometría de Masas , Metilación , Ramipril/uso terapéutico , Estándares de Referencia , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Manejo de Especímenes/normas , Estudios de Validación como Asunto
18.
Pediatr Dev Pathol ; 13(1): 66-71, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-19425818

RESUMEN

Females with 46,XY complete gonadal dysgenesis are at significant risk of developing germ cell tumors, mostly gonadoblastomas. We present here the case of 2 half-sisters, sharing the same father, diagnosed with 46,XY complete gonadal dysgenesis. The 1st sister developed a gonadoblastoma and an invasive dysgerminoma, whereas the 2nd sister developed a gonadoblastoma and an invasive choriocarcinoma within the same gonad. No SRY mutation, chromosome abnormalities, or mosaicism were detected in blood. Single nucleotide polymorphism (SNP) profiling of the choriocarcinoma revealed a complex hyperdiploid pattern with gains of 1 to 4 copies of material from several autosomes, as well as the loss of the Y chromosome and a homozygous SNP profile without copy number change for the X chromosome. Our results are in agreement with the recurrent chromosome gains and losses previously published in germ cell tumors, and the coexistence of both tumors within the same gonad suggests that choriocarcinomas may derive from gonadoblastomas.


Asunto(s)
Coriocarcinoma no Gestacional/genética , Disgerminoma/genética , Disgenesia Gonadal 46 XY/genética , Gonadoblastoma/genética , Neoplasias Primarias Múltiples , Polimorfismo de Nucleótido Simple , Neoplasias Uterinas/genética , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Quimioterapia Adyuvante , Niño , Coriocarcinoma no Gestacional/patología , Coriocarcinoma no Gestacional/terapia , Deleción Cromosómica , Cromosomas Humanos Y , Disgerminoma/patología , Disgerminoma/terapia , Resultado Fatal , Femenino , Disgenesia Gonadal 46 XY/patología , Disgenesia Gonadal 46 XY/terapia , Gonadoblastoma/patología , Gonadoblastoma/terapia , Humanos , Hibridación Fluorescente in Situ , Análisis de Secuencia por Matrices de Oligonucleótidos , Hermanos , Cariotipificación Espectral , Neoplasias Uterinas/patología , Neoplasias Uterinas/terapia , Adulto Joven
19.
Bioanalysis ; 1(3): 537-48, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21083151

RESUMEN

BACKGROUND: Anticoagulants are used to prevent coagulation in blood samples. The plasma pH may change with a different counter ion and anticoagulant; thus, it is essential to determine effects on drug stability and the matrix effect during the bioanalytical method development. RESULTS: Cross-validation of multiple compounds between different counter ions was performed and no impact from the counter ion nature was demonstrated. Moreover, plasma stabilities and matrix effects for both fluconazole and granisetron were investigated thoroughly in numerous counter ions/anticoagulants (K(3)ethylenediaminetetraacetic acid [K(3)EDTA], K(2)EDTA, NaEDTA, NaHeparin and LiHeparin). Sirolimus, a large cyclic molecule, was also tested in different whole-blood EDTA counter ions. Results showed percentage deviation less than 8.5% and percentage cross-validation less than 8.4%. CONCLUSION: None of the compounds tested had an impact on the matrix stabilities and matrix effect.


Asunto(s)
Anticoagulantes/sangre , Anticoagulantes/química , Ácido Edético/química , Heparina/química , Anticoagulantes/farmacología , Cromatografía de Fase Inversa , Estabilidad de Medicamentos , Fluconazol/sangre , Granisetrón/sangre , Humanos , Concentración de Iones de Hidrógeno , Iones , Límite de Detección , Preparaciones Farmacéuticas , Sirolimus/sangre , Espectrometría de Masa por Ionización de Electrospray
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda